Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Semtech (SMTC) Hits 52-Week High On Bullish Growth Trends

Published 04/10/2018, 10:22 PM
Updated 07/09/2023, 06:31 AM

Semtech Corporation’s (NASDAQ:SMTC) shares hit a new 52-week high of $43.35 on Apr 10, closing a shade lower at $42.80. Barring minor hiccups, Semtech’s share price has steadily been on an uptrend. The stock has the potential for further price appreciation with long-term earnings growth expectation of 5%.

The company’s surprise history has been pretty impressive. It beat estimates in all of the trailing four quarters, with an average positive surprise of 6.08%.

Over the last year, the company’s shares have gained 30.9%, outperforming its industry’s 16.3% rally.

Key Factors

Semtech is currently riding on differentiated growth drivers and diversification strategy. Key growth drivers for Semtech are product differentiation, operational flexibility, and specific focus on fast-growing segments and regions.

We believe that the company’s new design wins, product launches and perfect execution will take it from strength to strength.

The price appreciation can be attributed to the company’s strong fiscal fourth-quarter earnings. In the fiscal fourth quarter, results of which were reported on Mar 14, earnings of 42 cents per share beat the Zacks Consensus Estimate. Also, Semtech’s revenues of $140.6 million increased year over year. The increase was driven by a strong demand, reinforcing the company’s enterprise computing end market.

The company’s unrivalled market position, compelling product lines, strong revenue growth, continued innovation and strong long-term growth potential consolidate its market presence favorably.

For first-quarter fiscal 2019, management expects revenues in the range of $147-$153 million. This implies 7% sequential increase at the mid-point of the guided range. The Zacks Consensus Estimate is pegged at $150.2 million. Non-GAAP earnings per share are expected in the range of 45-47 cents. This implies a 10% sequential increase at the mid-point of the guided range. The Zacks Consensus Estimate is pegged at 46 cents.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Such a bullish outlook with continued growth impetus and core focus perhaps gave a boost to investors’ confidence and catapulted its share price to a new 52-week high.

Zacks Rank & Stocks to Consider

Semtech has a Zacks Rank #3 (Hold).Some better-ranked stocks in the technology sector are Stamps.com Inc. (NASDAQ:STMP) , PetMed Express (NASDAQ:PETS) and Agilent Technologies (NYSE:A) . While Stamps.com sports a Zacks Rank #1 (Strong Buy), PetMed and Agilent carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings per share growth rate for Stamps.com, PetMed and Agilent is projected to be 15%, 10% and 10.8%, respectively.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



PetMed Express, Inc. (PETS): Free Stock Analysis Report

Stamps.com Inc. (STMP): Free Stock Analysis Report

Semtech Corporation (SMTC): Free Stock Analysis Report

Agilent Technologies, Inc. (A): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.